Fifth Third Bancorp
GEVA

Fifth Third Bancorp’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Fifth Third Bancorp’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,532
Closed -$149K – 3002
2015
Q1 		$149K Buy
1,532
+581
+61% +$61.5K ﹤0.01% 1069
2014
Q4 		$88K Buy
+951
New +$75K ﹤0.01% 1206

Fifth Third Bancorp's GEVA Position: Q2 2015 in Review

Fifth Third Bancorp sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 1,532 shares — an estimated $149K sold.

Fifth Third Bancorp first reported a position in GEVA in Q4 2014 and held it in 2 quarters. The position peaked at $149K in Q1 2015. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • Fifth Third Bancorp reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Fifth Third Bancorp sold 1,532 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $149K.
  • Fifth Third Bancorp first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q4 2014 and held it in 2 quarters.
  • Fifth Third Bancorp's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $149K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Fifth Third Bancorp's 13F filing for Q2 2015, filed 14 Aug 2015.